APA (7th ed.) Citation

G, W., TAM, M., X, M., I, S., D, D. C. P., R, B., . . . R, L. (2023). SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism. Archiv der Pharmazie, 356(1), e2200451. https://doi.org/10.1002/ardp.202200451

Chicago Style (17th ed.) Citation

G, Wágner, et al. "SAR Exploration of the Non-imidazole Histamine H3 Receptor Ligand ZEL-H16 Reveals Potent Inverse Agonism." Archiv Der Pharmazie 356, no. 1 (2023): e2200451. https://doi.org/10.1002/ardp.202200451.

MLA (9th ed.) Citation

G, Wágner, et al. "SAR Exploration of the Non-imidazole Histamine H3 Receptor Ligand ZEL-H16 Reveals Potent Inverse Agonism." Archiv Der Pharmazie, vol. 356, no. 1, 2023, p. e2200451, https://doi.org/10.1002/ardp.202200451.